Covering Every Major Catalyst
1. FDA Approvals & Trial Results
Be the first to know about PDUFA decisions, Phase 1/2/3 data, and FDA clearances. Catch the explosion in biotech stocks before the halt is lifted.
2. M&A & Buyouts
Instant alerts for definitive agreements, tender offers, and hostile takeovers. Trade the acquisition premium instantly.
3. Strategic Contracts
Identify small-cap companies securing massive government or commercial contracts. Our AI highlights the contract value relative to market cap.
4. Partnerships & Licensing
Spot strategic alliances with industry giants. From tech licensing to distribution deals, find the stocks 'partnering up' for growth.
5. Offerings & Dilution
Distinguish between strategic investments and toxic dilution. Get alerted on Direct Offerings, Private Placements, and S-3 filings instantly.
6. Insider Buying & Form 4
Follow the smart money. Get alerted instantly when CEOs and Directors purchase shares on the open market, signaling strong confidence before a major catalyst.
About KairAlert
Institutional Speed. Retail Accessibility.
In today's market, timing is everything. By the time a headline hits social media, the opportunity is often
gone.
KairAlert is designed to close this gap. We are not just a news aggregator; we are an Alpha Generation Engine.
Our mission is simple: to democratize access to professional market intelligence. We ensure independent day
traders have the precision, speed, and clarity needed to make confident decisions in a fast-moving market.
Every day, over 20,000 corporate releases hit the wires. 99% is noise.
KairAlert's proprietary NLP (Natural Language Processing) algorithms ingest raw data streams directly from the
source in milliseconds.
Our proprietary AI engine monitors a vast array of data sources 24/7, including:
- SEC Filings: Direct SEC EDGAR Feed (8-K, S-3, Form 4).
- FDA Calendar & Events: Tracking PDUFA dates, clinical trial results, and approvals.
- PR Wires: Real-time scanning of major press release circuits for breaking news.
FAQs
-
How is KairAlert Different from Traditional News Sites?
Most traditional news sites focus on the news itself. They are weak on classification, core summarization, stock matching, and filtering. They can't push news to users with precision.
When using a traditional news site or broker app, the user must actively pull all news for a stock or the market, then manually categorize and filter it.
With thousands of listed companies, it's impossible to actively find that critical, first-hand information quickly.
KairAlert does the exact opposite. It ingests as much news as possible, matches it to a ticker, and if it's deemed valuable by the algorithm, passively pushes it to the user. For the trader, this means you are passively receiving high-value, pre-filtered news. This dramatically saves time and increases the efficiency of capturing high-value information. -
How many alerts does KairAlert send per day?
The number varies daily, depending on the volume from upstream sources and the results of our algorithm.
It could be anywhere from zero to several dozen. -
What trading style is KairAlert suited for?
KairAlert is designed for trading news-driven volatility. This means ultra short-term, "in-and-out" trades, often completed within minutes.
It focuses primarily on small-cap stocks (under $1B market cap) and pushes alerts related to: Mergers/Acquisitions, Financing, Strategic Partnerships, and FDA-related news.
Disclaimer: KairAlert is a news aggregation and filtering tool. Nothing in its feed constitutes investment advice. Ultra short-term trading carries extremely high risk; please make decisions based on your own judgment. -
Is KairAlert free?
KairAlert is currently in its early product iteration and validation phase, and it is completely free to use.
We want this to be a zero-risk, no-barrier trial for you. No credit card or payment information is required. You can get started immediately.
We promise a free-use period of at least 3 months (starting from December 2025). During this time, we sincerely hope to receive your valuable feedback to help us refine and perfect KairAlert.
To provide you with a true "Edge," KairAlert requires substantial, ongoing investment in several core areas:
1. Accessing and maintaining an extensive network of news feeds and massive amounts of market transaction data. This requires significant human and financial capital, as the vast majority of high-speed news channels and data sources are premium, paid services.
2. Continuously optimizing algorithmic strategies and Big Data models. This sustained R&D investment is essential to guarantee comprehensive news coverage, ultra-low latency delivery, and unwavering service stability.
3. Supporting robust cloud infrastructure. Ensuring KairAlert operates 24/7 and processes massive volumes of data in real-time relies heavily on substantial resources in cloud computing, storage, and high-performance computing (HPC).
4. Ongoing product evolution. Rolling out new features, iterations, and maintenance requires continuous development resources.
For these reasons, KairAlert will transition to a paid subscription service after the free trial period. However, we have not yet determined a clear pricing model. -
What is on the future roadmap for KairAlert?
Features currently on our roadmap include:
1. FDA Calendar: Alerts for key FDA dates and events.
2. Large-Order Flow: Pushing alerts for potentially impactful large-order trades (focusing on SPY, QQQ, IWM, IWF, IWD, IWP, etc.).
3. SEC Filings Monitor: Monitoring SEC filings (Forms 6-K, 8-K, 4) and alerting on high-value events.
4. Unusual Volatility Alerts: Monitoring for and alerting on unusual stock movements. -
How to contact you?
You can contact us through the following channels:
1. Email: support@kairalert.pro
2. Twitter: @zdying2024
3. Discord: Join Community